Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Maximaa Systems's Days Payable or its related term are showing as below:
BOM:526538's Days Payable is not ranked *
in the Drug Manufacturers industry.
Industry Median: 88.385 * Ranked among companies with meaningful Days Payable only.
Maximaa Systems's Days Payable
increased
from Sep. 2020 (130.58) to Sep. 2021 (1,845,835.42).
It may suggest that Maximaa Systemsdelayed paying its suppliers.
The historical data trend for Maximaa Systems's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Maximaa Systems's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Maximaa Systems Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Maximaa Systems's Days Payable distribution charts can be found below:
* The bar in red indicates where Maximaa Systems's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Maximaa Systems's Days Payable for the fiscal year that ended in Mar. 2021 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Maximaa Systems (BOM:526538) has a Days Payable of 1,845,835.42 as of Sep. 2021. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Maximaa Systems and its competitors.
Is Maximaa Systems' Days Payable too high?
Maximaa Systems' current Days Payable is 1,845,835.42. The Drug Manufacturers industry median Days Payable is 88.39. Maximaa Systems' value of 1,845,835.42 is 2088303.5% above this industry median. Overall, Maximaa Systems has a GF Score™ of 4/100, reflecting its overall financial health beyond just this single metric.
How does Maximaa Systems' Days Payable compare to ZTS?
Maximaa Systems' Days Payable of 1,845,835.42 can be compared against companies in the Drug Manufacturers industry. The industry median Days Payable is 88.39. Maximaa Systems' value of 1,845,835.42 is 2088303.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 88.39, based on 928 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Maximaa Systems's current Days Payable of 1,845,835.42 is 2088303.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Maximaa Systems and its competitors. For the Drug Manufacturers industry, the median Days Payable is 88.39 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Maximaa Systems's current Days Payable is 1,845,835.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maximaa Systems stock overvalued right now?
Maximaa Systems (BOM:526538) has a current Days Payable of 1,845,835.42. The current Days Payable is 1,845,835.42 and 2088303.5% above the Drug Manufacturers industry median of 88.39. Maximaa Systems' overall GF Score™ is 4/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Maximaa Systems (BOM:526538), the current Days Payable is 1,845,835.42 as of Sep. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Maximaa Systems Ltd is an India-based company operating in two principal business divisions: storage systems and pharmaceuticals. Through its storage systems division, it manufactures and supplies industrial storage and material-handling solutions, including heavy-duty pallet racking, medium-duty racking, drive-in storage systems, slotted angle racks, two-tier and three-tier racking, mobile storage systems, compactors, and furniture storage products. These products serve warehouses, factories, and commercial establishments seeking organized storage infrastructure. Its pharma division offers healthcare products focused on bone and joint care, hair care, neuro care, and skincare. The company primarily serves customers within the Indian market, generating revenue through the sale of its storage equipment and healthcare product lines. Its dual-segment structure combines an industrial equipment business with a consumer healthcare products business, targeting both institutional and retail customers across India.
4GF Score
Get the complete analysis for BOM:526538
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:526538 has been successfully added to your 
